29
Alcohol Brian J. Piper, Ph.D. 1.0

Neuropharmacology: Alcohol

Embed Size (px)

DESCRIPTION

Lecture 5 from a college level neuropharmacology course taught in the spring 2012 semester by Brian J. Piper, Ph.D. ([email protected]) at Willamette University. Includes epidemiology, pharmacokinetics, pharmacodynamics, and overdose.

Citation preview

Page 2: Neuropharmacology: Alcohol

Goals

• Chemistry• Pharmacokinetics• Pharmacodynamics• Physiological effects• Public health consequences• Teratology• Epidemiology

1.2

Page 3: Neuropharmacology: Alcohol

Chemistry

• Ethanol: CH3CH2OH

1.2

Page 4: Neuropharmacology: Alcohol

Getting in:

• 1. Mouth• 2. Stomach• 3. Small intestine• 4. Heart• 5. Brain• 6. Liver

1.3

Page 5: Neuropharmacology: Alcohol

Getting out

• Alcohol dehydrogenase (AlcDH):

• Aldehyde dehydrogenase (AldDH)

• Ethanol --------> Acetaldehyde ------> Acetic Acid

CH3-CH2-OH CH3-CH=O CH3-C-OH

O

AlcDH: lower levels in stomach of women

AldDH: half of Asians have a dysfunctional version; this results in flushing and nausea, Antabuse inhibits

AlcDH AldDH

||

See also: http://endeavor.med.nyu.edu/~strone01/doctor.html

3.7

Page 6: Neuropharmacology: Alcohol

Sex Differences

• Lower level of AlcDH in stomach of females

• Fat content

• Sex hormones

• Tolerance

2.7

Page 7: Neuropharmacology: Alcohol

Pharmacodynamics

• Primary– decrease glutamate– increase GABA

• Secondary– increase Dopamine

1.8

Page 8: Neuropharmacology: Alcohol

Doyon, W.M.,et al. (2005). J Neurochem, 93, 1469-1481.

3.1

Page 9: Neuropharmacology: Alcohol

Physiological Effects

• Dose dependent: – low dose-stimulant– high dose-depressant

5.1

Blood Alcohol Concentration Symptom

Low (O.01%*) relaxationDecreased alertness

Loss of coordination/ reaction time

Difficulty standing/ walking

Slurred speech

Unable to walk unaided

Difficulty rousing

Coma

High (0.50) Death

Table From Inaba, D.S. (2007).

*Mass/Volumemg/dL

Page 10: Neuropharmacology: Alcohol

2004 Fatalities in Motor Vehicle Traffic Crashesby Driver BAC – Massachusetts

.15+ BAC 62.6%

.10-.14 BAC 26.4%

.08-.09 BAC 11.0%

.08+ BAC 34.5%

.01-.07BAC4.7%

Zero BAC 61.1%

Source: National Highway Traffic Safety Administration, U.S. Department of Transportation, 2005. Fatalities in motor vehicle traffic crashes by the highest driver BAC in the crash, 2004 Fatal Analysis Reporting System (FARS).

The average BAC among drunk drivers involved in fatal crashes was 0.17 (2004).

2.9

Page 11: Neuropharmacology: Alcohol

Preventabledeaths.

http://www-nrd.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2005/810616.pdftp://.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2005/810616.pdf

Alcohol related fatality = one member of accident (driver, nonoccupant) has detectable Alcohol (0.01 g/dl +) ,

There were 43,295 traffic fatalities (39% alcohol related).

Page 12: Neuropharmacology: Alcohol

Chronic EtOH & Neurophsyiology

Chorlian, D.B. (1995). Alcohol Health & Research World 19(4):315–320.

3.3

Find X among other letters,“Oddball” task

Page 13: Neuropharmacology: Alcohol

Chronic EtOH & Neuroanatomy

Rosenbloom, M., et al. (2003). Alcohol Research & Health 27(2):146–152.

2.6

Page 14: Neuropharmacology: Alcohol

Teratology: High dose1.5

Warren, Kenneth (2011). Perspectives on Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders. Available at: http://videocast.nih.gov/launch.asp?16613

Page 15: Neuropharmacology: Alcohol

Low-Dose?• Women in Capetown, South Africa were interviewed after giving birth and their

offspring were grouped as:

– Unexposed Control (N=29): no EtOH

– Fetal Alcohol Syndrome (N=12): 4.2 drinks/day

– Partial FAS (N=18): 2.8 drinks/day

– Heavy Exposed (N=34): 1.6 drinks/day

– Microencephalic (N=4): ?

• Children were tested at age 5

for classical conditioning:

Jacobson, S.W., et al. (2008). Alcohol: Clin Exp Res 37, 2, 365-372.

http://www.nlm.nih.gov/medlineplus/ency/images/ency/fullsize/17256.jpghttp://www.nlm.nih.gov/medlineplus/ency/images/ency/fullsize/17256.jpg

Page 16: Neuropharmacology: Alcohol

Jacobson, S.W., et al. (2008). Alcohol: Clin Exp Res 37, 2, 365-372.

Page 17: Neuropharmacology: Alcohol

Monitoring the Future

• National survey, conducted annually by NIDA of secondary school (8th, 10th, or 12th), college students, and adults (<45 yrs)

• Missing data (drop-outs = 15%, not attending) = under-estimation

• Concern about labels (inadvertent marketing)• Self-report

– Knowledge (e.g. steroids, diet pills, club drugs)– Memory (e.g. How many drinks?)– Taboo

http://www.monitoringthefuture.org/

Page 18: Neuropharmacology: Alcohol

Demographics

• Compares use by:– Year (1975 – present)– Sex– Ethnicity– Parental education– Region– College plans

?

Page 19: Neuropharmacology: Alcohol
Page 20: Neuropharmacology: Alcohol

Frequency of Alcohol Use

• Monitoring the Future

• Nationally representative

• 15,000+

Page 21: Neuropharmacology: Alcohol

Frequency of Alcohol Use

• Monitoring the Future

• Nationally representative

• 15,000+

Page 22: Neuropharmacology: Alcohol

Epidemiology

MtF: http://www.monitoringthefuture.org/pubs/occpapers/occ63.pdf

Page 23: Neuropharmacology: Alcohol
Page 24: Neuropharmacology: Alcohol

http://www.monitoringthefuture.org/data/06data/fig06_14.pdf

Page 25: Neuropharmacology: Alcohol

Drug Abuse Warning Network

• Nationwide reports of ER/ED visits

• 242 hospitals nationwide

• Drug/alcohol is “implicated”– Overdose– Suicide– Accident

Page 26: Neuropharmacology: Alcohol

Drug Abuse Warning Network

Page 27: Neuropharmacology: Alcohol

Alcoholics Anonymous

• Founded by Bill Wilson & Bob Smith in 1935• Medical-Spiritual Approach based on:

– Alcoholism is a progressive disease.– Alcoholics must give themselves to a higher power.– Total abstinence

• Effectiveness ?

3.5

Page 28: Neuropharmacology: Alcohol

Public Health

Nutt, D.J. (2006) J. Psychopharmacology, 20, 315-317.

Premature Deaths (UK)

Safety in

overdose

Brain

Damage

Interpersonal

Violence

Traffic

Accidents

Per year

cirrhosis Heart Damage

Cost

to society (Billion Pounds)

ethanol 22,000 10 xPleasure

dose

Yes10,000 +/year 1500 ++ ++ 18.5

ecstasy 10 15 x ? 0 0 0 0 0.01

Page 29: Neuropharmacology: Alcohol

Summary

• Pharmacokinetics: enzymes

• Pharmacodynamics: neurotransmitters

• Teratology: consequences– Randall: http://videocast.nih.gov/launch.asp?10420

• Epidemiology: Who uses? What are risk factors?

Total Length = 57.4 minutes